Characteristic | Placebo (n = 74) | Vortioxetine (n = 73) | p-value* |
---|---|---|---|
Age (Years), Mean (SD) | 44.89 (12.14) | 43.84 (12.35) | 0.602a |
Sex (Female), n (%) | 55 (74.32) | 56 (76.71) | 0.736b |
Education, n (%) | 0.390b | ||
< High School | 0 (0) | 1 (1.37) | Â |
High School Graduate | 4 (5.41) | 8 (10.96) | |
College/University Degree | 10 (13.51) | 7 (9.59) | |
Associates Degree | 15 (20.27) | 13 (17.81) | |
Bachelor’s Degree | 27 (36.49) | 34 (46.58) | |
Graduate Degree | 15 (20.27) | 9 (12.33) | |
Professional Degree | 3 (4.05) | 1 (1.37) | |
Confirmed COVID Diagnosis, n (%) | 59 (79.7) | 57 (78.1) | 0.807b |
QIDS-SR-16 (Total Score), Mean (SD) | 10.32 (4.37) | 10.03 (4.33) | 0.681a |
MDD Diagnosis, n (%) | 25 (33.78) | 22 (30.14) | 0.595b |
FSS (Total Score), Mean (SD) | 51.84 (10.20) | 49.78 (10.96) | 0.083a |
Walking Days per Week, Mean (SD) | 4.18 (2.53) | 4.62 (2.43) | 0.283a |
Remote Assessment, n (%) | 69 (93.24) | 67 (91.78) | 0.736b |
Combined DSST Z-score, Mean (SD)c | -0.194 (0.99) | 0.0531 (1.01) | 0.136a |
CRP, Mean (SD) | 3.07 (3.37) | 2.43 (2.96) | 0.276a |
TRG-HDL, Mean (SD) | 3.62 (0.99) | 5.81 (17.19) | 0.376a |
BMI, Mean (SD) | 31.25 (7.49) | 29.03 (9.05) | 0.113b |
Normal Weight | 21.99 (2.31) | 22.57 (1.52) | Â |
Overweight | 27.93 (1.40) | 27.69 (1.56) | |
Obese | 37.99 (4.98) | 40.51 (8.33) |